Skip to main content
Anand Srivastava, MD, Nephrology, Chicago, IL

Anand Srivastava MD


Physician

Join to View Full Profile
  • 1801 W Taylor StSuite 3DChicago, IL 60612

  • Phone+1 312-413-5569

Dr. Srivastava is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2013 - 2017
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2010 - 2013
  • Saint Louis University School of Medicine
    Saint Louis University School of MedicineClass of 2010

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2017 - 2026
  • MA State Medical License
    MA State Medical License 2014 - 2017
  • TX State Medical License
    TX State Medical License 2012 - 2014
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Nephrology
    American Board of Internal Medicine Nephrology

Publications & Presentations

PubMed

Press Mentions

  • UIC Researchers to Lead Large-Scale Noninvasive Study of Chronic Kidney Disease
    UIC Researchers to Lead Large-Scale Noninvasive Study of Chronic Kidney DiseaseJuly 8th, 2025
  • In CKD, Proteinuria Provides Many Kinds of Prognostic Value
    In CKD, Proteinuria Provides Many Kinds of Prognostic ValueJuly 1st, 2025
  • GIOSTAR Announces FDA Clearance of the IND for Starting PHASE-2 Clinical Trial for Developing Specific Stem Cell Therapy for Type II Diabetes
    GIOSTAR Announces FDA Clearance of the IND for Starting PHASE-2 Clinical Trial for Developing Specific Stem Cell Therapy for Type II DiabetesNovember 13th, 2024

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: